Confidential Treatment. The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.
Confidential Treatment. Customer understands that certain commercial and financial information contained in this Letter Agreement are considered by Boeing as confidential. Customer agrees that it will treat this Letter Agreement and the information contained herein as confidential and will not, without the prior written consent of Boeing, disclose this Letter Agreement or any information contained herein to any other person or entity.
Confidential Treatment. All information and advice furnished by one party to the other party (including their respective agents, employees and representatives and the agents, employees, and representatives of any affiliates) hereunder shall be treated as confidential and shall not be disclosed to third parties, except as may be necessary to comply with applicable laws, rules and regulations, subpoenas, court orders, and as required in the administration and management of the Funds. It is understood that any information or recommendation supplied or produced by Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Without limiting the foregoing, the Adviser and the Trust will only disclose portfolio information in accordance with the Trust’s portfolio information policy as adopted by the Board of Trustees.
Confidential Treatment. The information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. Customer will limit the disclosure of its contents to employees of Customer with a need to know the contents for purposes of helping Customer perform its obligations under the Purchase Agreement and who understand they are not to disclose its contents to any other person or entity without the prior written consent of Boeing. AAL- LA-1106678 BOEING PROPRIETARY [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] Very truly yours, THE BOEING COMPANY By: Its: Attorney-In-Fact ACCEPTED AND AGREED TO this Date: AMERICAN AIRLINES, INC. By: Its: AAL- LA-1106678 BOEING PROPRIETARY [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] The Boeing Company X.X. Xxx 0000 Xxxxxxx, XX 00000-0000 EXHIBIT 4B To 2012 Omnibus Restructure Agreement (Form of [*CTR]) [*], 20[*] American Airlines, Inc. P.O. Box 619616 MD 0000 Xxxxxx/Xxxx Xxxxx Xxxxxxx, XX 00000-0000 Attention: Xxxxxxx X. Xxxxxx, Vice President and Treasurer Ladies and Gentlemen: We refer to (a) that certain 2012 Omnibus Restructure Agreement, dated [*], 20[*] (the “Omnibus Agreement”), between The Boeing Company (“Boeing”) and American Airlines, Inc. (“American”), and [*CTR] The parties hereby agree as follows:
Confidential Treatment. All information and advice furnished by one party to the other party (including their respective agents, employees and representatives) hereunder shall be treated as confidential and shall not be disclosed to third parties, except as may be necessary to comply with applicable laws, rules and regulations, subpoenas or court orders. It is understood that any information or recommendation supplied by, or produced by, Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Without limiting the foregoing, the Adviser and the Trust will only disclose portfolio information in accordance with the Trust’s portfolio information policy as adopted by the Board of Trustees.
Confidential Treatment. It is understood that any information or recommendation supplied by, or produced by, Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Furthermore, except as required by law (including, but not limited to semi-annual, annual or other filings made under the 0000 Xxx) or as agreed to by the Adviser and Sub-Adviser, the Adviser and Trust will not disclose any list of securities held by the Fund until it is either filed with the Securities & Exchange Commission or mailed out to shareholders, which filing or mailing shall not be made sooner than 30 days after quarter end in any manner whatsoever except as expressly authorized in this Agreement, except that the top 10 holdings may be disclosed 15 days after month end. In addition, at the end of each quarter, the Adviser may disclose to certain third party data or service providers to the Fund, who have entered into a confidentiality agreement with the Adviser, a list of securities purchased or sold by the Fund during the quarter.
Confidential Treatment. Customer understands and agrees that the information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. Customer agrees to limit the disclosure of its contents to employees of Customer with a need to know the contents for purposes of helping Customer perform its obligations under the Purchase Agreement and who are under an obligation not to disclose its contents to any other person or entity without the prior written consent of Boeing. “[***]” This information is subject to confidential treatment and has been omitted and filed separately with the commission BOEING PROPRIETARY Very truly yours, THE BOEING COMPANY By Its Attorney-In-Fact ACCEPTED AND AGREED TO this Date: XIAMEN AIRLINES By Its Attachment “[***]” This information is subject to confidential treatment and has been omitted and filed separately with the commission BOEING PROPRIETARY ATTACHMENT 787 DIFFERENCES TRAINING POINTS MENU 787 Training Courses Per Class Student Maximum [*********]* Maintenance 787-8 to 787-9 or 787-9 to 787-8 Maintenance Training Differences Class [***] [***] [*********] are based upon training conducted according to Boeing’s standard training courses. Extended or modified courses will require point adjustment to reflect altered work statement or duration. The courses and products listed in this Attachment are subject to change from time to time as new courses are added and courses are removed. Boeing reserves the right to change course offering at its own discretion. “[***]” This information is subject to confidential treatment and has been omitted and filed separately with the commission BOEING PROPRIETARY XIA-PA-03586-LA-1501316 Xiamen Airlines 20 Xxxxxxx Xxxx Xxxxxx, 000000 Xxxxxx Xxxxxxxx People’s Republic of China Subject: Special Matters – Model 787-9 Reference: Purchase Agreement No. PA-03586 (Purchase Agreement) between The Boeing Company (Boeing) and Xiamen Airlines (Customer) relating to Model 787-9 aircraft (787-9 Aircraft) This letter agreement (Letter Agreement) amends and supplements the Purchase Agreement. All terms used but not defined in this Letter Agreement shall have the same meaning as in the Purchase Agreement.
Confidential Treatment. Customer and Boeing understand and agree that the information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. Customer and Boeing agree to limit the disclosure of its contents to employees of Customer and Boeing with a need to know the contents for purposes of helping Customer and Boeing perform their obligations under the Purchase Agreement and who understand they are not to disclose its contents to any other person or entity without the prior written consent of the other party hereto. BOEING PROPRIETARY DATED AS OF FEBRUARY 1, 2013 AMERICAN AIRLINES, INC. THE BOEING COMPANY BY: /s/ American Airlines, Inc. BY: /s/ The Boeing Company ITS: VP Corporate Development ITS: Attorney In Fact and Treasurer P.A. No. 3219 SA-3 BOEING PROPRIETARY Table 1(R2) to Purchase Agreement No. PA-03219 787-9 Aircraft Delivery, Description, Price and Advance Payments Airframe Model/MTOW: 787-9 545000 pounds Detail Specification: [****] Engine Model/Thrust: GENX-1B74/75 74100 pounds Airframe Price Base Year/Escalation Formula: [****] [****] Airframe Price: [****] Engine Price Base Year/Escalation Formula: [****] [****] ]]][Optional Features: [****] Sub-Total of Airframe and Features: [****] Airframe Escalation Data: Engine Price (Per Aircraft): [****] Base Year Index (ECI): [****] Aircraft Basic Price (Excluding BFE/SPE): [****] Base Year Index (CPI): [****] Buyer Furnished Equipment (BFE) Estimate: [****] Engine Escalation Data: Base Year Index (ECI): [****] In-Flight Entertainment (IFE) Estimate: [****] Base Year Index (CPI): [****] Deposit per Aircraft: [****] Delivery Date Number ofAircraft Escalation Factor (Airframe) EscalationFactor (Engine) ManufacturerSerial No. Escalation EstimateAdv Payment BasePrice Per A/P Advance Payment Per Aircraft (Amts. Due/Mos. Prior to Delivery): [****] [****] [****] Total [****] [****]-2015 1 [****] [****] [****] [****] [****] [****] [****] [****] [****]-2016 1 [****] [****] [****] [****] [****] [****] [****] [****] [****]-2016 1 [****] [****] [****] [****] [****] [****] [****] [****] [****]-2016 1 [****] [****] [****] [****] [****] [****] [****] [****] [****]-2016 1 [****] [****] [****] [****] [****] [****] [****] [****] [****]-2016 1 [****] [****] [****] [****] [****] [****] [****] [****] [****]-2016 1 [****] [****] [****] [****]] [****] [****] [****] [****] [****]-2016 1 [****] [****] [****] [****] [****] [****] [****] [****] AAL-PA-03219 6189...
Confidential Treatment. Boeing and Customer understand that certain information contained in this Letter Agreement is considered to be confidential. The parties agree that they will treat this Letter Agreement and the information contained herein as confidential and will not, without the prior written consent of the other party, disclose this Letter Agreement or any information contained herein to any other person or entity except, (1) to those of their respective legal counsel, auditors, accountants, insurance brokers and other advisers who have a need to know the information for purposes of interpreting Customer’s rights or interpreting or performing Customer’s obligations under the Purchase Agreement, subject to such parties’ written agreements that they will treat the information as confidential, (2) to a bank for the sole purpose of financing of the purchase of such Aircraft and subject to such bank’s written agreement that it will treat the information as confidential, (3) as required by the rules of any stock market applicable to the parties on condition that the party wishing to make such disclosure shall first use reasonable efforts to seek relief from the risk of disclosure to competitors or others with whom either of the parties has business relations of information which might be detrimental to the interest of either of the parties, or (4) as may be required by applicable law. P.A. No. 3323 Liquidated_Damages_Non-Excusable_Delay BOEING PROPRIETARY Xiamen Airlines 6-1165-CKR-1446 Very truly yours, THE BOEING COMPANY By /s/ Xxxxxxxxx X. Xxxxxx Its Attorney-In-Fact ACCEPTED AND AGREED TO this Date: April 18, 2008 XIAMEN AIRLINES By /s/ Xxxx Xxxxx Hua Its P.A. No. 3323 Liquidated_Damages_Non-Excusable_Delay BOEING PROPRIETARY The Boeing Company X.X. Xxx 0000 Xxxxxxx, XX 00000-0000 6-1165-CKR-1447 Xiamen Airlines 00 Xxxxxxx Xxxx Xxxxxx, 000000 Xxxxxx Xxxxxxxx People’s Republic of China Subject: Aircraft Performance Guarantees Reference: Purchase Agreement No. 3323 (the Purchase Agreement) between The Boeing Company (Boeing) and Xiamen Airlines (Customer) relating to Model 737-85C aircraft (the Aircraft) This letter agreement (Letter Agreement) amends and supplements the Purchase Agreement. All terms used but not defined in this Letter Agreement have the same meaning as in the Purchase Agreement. Boeing agrees to provide Customer with the performance guarantees in the Attachment These guarantees are exclusive and expire upon delivery of the Aircraft to Customer. Boeing and ...
Confidential Treatment. All information and advice furnished by one party to the other party (including their respective agents, employees and representatives and the agents, employees, and representatives of any affiliates) hereunder shall be treated as confidential and shall not be disclosed to third parties, except as may be necessary to comply with applicable laws, rules and regulations, subpoenas, court orders, and as required in the administration and management of the Funds. It is understood that any information or recommendation supplied or produced by Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Without limiting the foregoing, the Adviser and the Trust will only disclose portfolio information in accordance with the Trust’s portfolio information policy as adopted by the Board of Trustees. The confidential treatment of the information noted in this Agreement shall also apply to information shared between the Adviser and the Sub-Adviser relating to potential future funds for which the Adviser may wish to retain the Sub-Adviser’s investment advisory services.
